FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways

Mol Cell. 2023 Aug 3;83(15):2810-2828.e6. doi: 10.1016/j.molcel.2023.07.004.

Abstract

DNA damage-activated signaling pathways are critical for coordinating multiple cellular processes, which must be tightly regulated to maintain genome stability. To provide a comprehensive and unbiased perspective of DNA damage response (DDR) signaling pathways, we performed 30 fluorescence-activated cell sorting (FACS)-based genome-wide CRISPR screens in human cell lines with antibodies recognizing distinct endogenous DNA damage signaling proteins to identify critical regulators involved in DDR. We discovered that proteasome-mediated processing is an early and prerequisite event for cells to trigger camptothecin- and etoposide-induced DDR signaling. Furthermore, we identified PRMT1 and PRMT5 as modulators that regulate ATM protein level. Moreover, we discovered that GNB1L is a key regulator of DDR signaling via its role as a co-chaperone specifically regulating PIKK proteins. Collectively, these screens offer a rich resource for further investigation of DDR, which may provide insight into strategies of targeting these DDR pathways to improve therapeutic outcomes.

Keywords: DDR signaling; FACS-based CRISPR screen; GNB1L; PRMT5; antibody; proteasome.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Ataxia Telangiectasia Mutated Proteins / genetics
  • Ataxia Telangiectasia Mutated Proteins / metabolism
  • Clustered Regularly Interspaced Short Palindromic Repeats*
  • DNA Damage*
  • Flow Cytometry
  • Genome
  • Humans
  • Protein-Arginine N-Methyltransferases / genetics
  • Repressor Proteins / genetics
  • Signal Transduction

Substances

  • Ataxia Telangiectasia Mutated Proteins
  • PRMT1 protein, human
  • Protein-Arginine N-Methyltransferases
  • Repressor Proteins
  • PRMT5 protein, human